Importantly, our studies suggest that TMEM43 S358L mutation contributes to cardiac fibrosis through NF-κB-TGFβ signal cascade during ARVD progress. The gene discussed is TMEM43; the disease is arrhythmogenic right ventricular cardiomyopathy.